Promethazine Dosing for First Trimester Nausea and Vomiting
For first-trimester nausea and vomiting of pregnancy, promethazine (Phenergan) should be dosed at 12.5-25 mg every 4-8 hours by oral route, with a maximum of 25 mg per dose. 1
Recommended Dosing Regimen
Based on the 2024 RCOG Green-Top Guideline, promethazine is a first-line antiemetic for nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG) 1. The specific dosing is:
- Oral route (preferred): 12.5-25 mg every 4-8 hours 1
- IM or IV route (if needed): 12.5-25 mg every 4-8 hours 1
- Maximum single dose: 25 mg 2
- Frequency: Not more often than every 4 hours 2
Clinical Context and Safety
Why Promethazine is First-Line
Promethazine is classified as a phenothiazine antihistamine (H1 receptor antagonist) with robust safety data in pregnancy. The 2024 RCOG guideline gives it a Grade A recommendation (Quality 2++) based on Cochrane review evidence showing no increased risk of congenital malformations or adverse pregnancy outcomes 1.
Practical Dosing Considerations
- Start with the lowest effective dose (12.5 mg) and titrate up to 25 mg if needed
- Oral route is strongly preferred over parenteral administration for safety reasons 2
- The FDA label specifies dosing for nausea/vomiting at 12.5-25 mg, not to be repeated more frequently than every 4 hours 2
Important Caveats
Sedation is the primary side effect. Research comparing promethazine to metoclopramide found significantly higher rates of:
- Drowsiness (83.6% vs 58.6%, p=0.001) 3
- Dizziness (71.2% vs 34.3%, p<0.001) 3
- Dystonia (19.2% vs 5.7%, p=0.02) 3
Counsel patients about:
- Marked drowsiness and impaired mental/physical abilities
- Avoiding driving or operating machinery
- Avoiding alcohol and other CNS depressants 2
Stepwise Treatment Algorithm
Per the 2024 RCOG guideline 1:
First-line options (choose one):
- Promethazine 12.5-25 mg every 4-8 hours PO
- Cyclizine 50 mg every 8 hours PO
- Prochlorperazine 5-10 mg every 6-8 hours PO
- Doxylamine-pyridoxine 20/20 mg at night
Second-line (if first-line ineffective):
- Metoclopramide 5-10 mg every 8 hours
- Ondansetron 4-8 mg every 8-12 hours
Third-line (severe, refractory cases):
- Corticosteroids (hydrocortisone or prednisolone)
Teratogenicity Concerns
While one 2023 case-control study suggested a possible association between promethazine and tetralogy of Fallot (aOR 1.49,95% CI 1.05-2.10) and craniosynostosis (aOR 1.44,95% CI 1.08-1.92) 4, this conflicts with the larger body of evidence. The 2024 RCOG guideline explicitly states no increased risk of congenital malformations based on Cochrane systematic review data 1. The FDA classifies promethazine as Pregnancy Category C, noting no demonstrated teratogenic effects in rat studies at therapeutic doses 2.
Route-Specific Warnings
If parenteral administration is necessary: